Skip to main content

Advertisement

SpringerLink
Log in

Biothérapies et MICI: meilleur cru 2008 à l’UEGW qu’à l’AGA

  • Alerte Scientifique / Scientific Alert
  • Published:
Côlon & Rectum

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. Colombel JF, Rutgeerts P, Reinisch W, et al (2008) SONIC: a randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn’s disease naive to immunomodulators and biologic therapy UEGW

  2. Feagan B (DDW 2008) Etude COMMIT (2008) A randomized trial of methotrexate (MTX) in combination with infliximab (IFX) for the treatment of Chron’s disease (CD). Late breaking abstract n° 682c

  3. Louis E, Vernier-Massouille G, Grimaud J, et al (2008) Étude STORI infliximab discontinuation in Crohn’s disease patients in stable remission on combined therapy with immunosuppressors: interim analysis of a prospective cohort study

Download references

Author information

Authors and Affiliations

  1. Service de gastroentérologie et d’assistance nutritive, PMAD, hôpital Beaujon, 100, boulevard du Général-Leclerc, F-92110, Clichy, France

    X. Treton

Authors
  1. X. Treton
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to X. Treton.

About this article

Cite this article

Treton, X. Biothérapies et MICI: meilleur cru 2008 à l’UEGW qu’à l’AGA. Colon Rectum 3, 51–52 (2009). https://doi.org/10.1007/s11725-009-0133-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11725-009-0133-0

Search

Navigation